InvestSMART

Medibank Private Limited (ASX: MPL) - Announcements

Current share price for MPL : $4.990 0.06 (1.22%)+

ASX company news and announcements for Medibank Private Limited (MPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibank Private Limited (MPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibank Private Limited (MPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibank Private Limited (MPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13,742 Notification of cessation of securities - MPL 6 Sep 2024 8:55AM $3.850 $4.990 risen by 29.61%
$13,742 Notification regarding unquoted securities - MPL 5 Sep 2024 9:09AM $3.900 $4.990 risen by 27.95%
$13,742 Change of Director's Interest - David Koczkar 5 Sep 2024 9:05AM $3.900 $4.990 risen by 27.95%
$13,742 Change of Director's Interest Notices 2 Sep 2024 8:28AM $3.860 $4.990 risen by 29.27%
$13,742 Change in substantial holding 28 Aug 2024 6:43PM $3.880 $4.990 risen by 28.61%
$13,742 FY24 Results - Investor Presentation 22 Aug 2024 8:01AM $3.920 $4.990 risen by 27.30%
$13,742 FY24 Results - Media Release 22 Aug 2024 8:01AM $3.920 $4.990 risen by 27.30%
$13,742 Dividend/Distribution - MPL 22 Aug 2024 8:00AM $3.920 $4.990 risen by 27.30%
$13,742 FY24 Results - Appendix 4E and Financial Report 22 Aug 2024 8:00AM $3.920 $4.990 risen by 27.30%
$13,742 Change of Registered Office 30 Jul 2024 8:28AM $3.830 $4.990 risen by 30.29%
$13,742 Notification of cessation of securities - MPL 4 Jul 2024 8:35AM n/a $4.990 n/a
$13,742 Notification regarding unquoted securities - MPL 2 Jul 2024 9:03AM $3.690 $4.990 risen by 35.23%
$13,742 Medibank cybercrime event - AIC files proceedings 5 Jun 2024 9:50AM $3.750 $4.990 risen by 33.07%
$13,742 Give back commitment increased to $305 million for customers 20 May 2024 8:29AM $3.630 $4.990 risen by 37.47%
$13,742 Updated Share Trading Policy 17 May 2024 9:05AM $3.710 $4.990 risen by 34.50%
$13,742 FY24 Full Year - Key Dates 17 May 2024 9:03AM $3.710 $4.990 risen by 34.50%
$13,742 Medibank shares business update and healthcare insights 7 May 2024 8:25AM $3.490 $4.990 risen by 42.98%
$13,742 Notification of cessation of securities - MPL 4 Apr 2024 9:09AM $3.740 $4.990 risen by 33.42%
$13,742 Initial Director's Interest - Jay Weatherill 22 Mar 2024 9:04AM $3.690 $4.990 risen by 35.23%
$13,742 Medibank announces approved premium increase 5 Mar 2024 10:19AM $3.730 $4.990 risen by 33.78%
$13,742 Change of Director's Interest - Linda Nicholls 29 Feb 2024 8:49AM $3.660 $4.990 risen by 36.34%
$13,742 Medibank appoints non-executive director 22 Feb 2024 8:10AM $3.860 $4.990 risen by 29.27%
$13,742 HY24 Results - Investor Presentation 22 Feb 2024 8:10AM $3.860 $4.990 risen by 29.27%
$13,742 HY24 Results - Media Release 22 Feb 2024 8:10AM $3.860 $4.990 risen by 29.27%
$13,742 Dividend/Distribution - MPL 22 Feb 2024 8:10AM $3.860 $4.990 risen by 29.27%

101 - 125 of 512 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.